Loading results ...
 

Blog Posts

Transforming the Connectivity of Global Biospecimen Data: Collaborative Industry, Academic and CRO Approaches.

For most research enterprises, data related to biological specimens is collected and archived in disparate databases, in non-standard formats and across many different locations around the world. New collaborative research models which encourage sample asset sharing within and across biopharmaceutical enterprises, academic medical research institutions, clinical research organizations, government and non-profit research foundations are challenging […]

Read more »

The Future of Automated Liquid Nitrogen Storage

The storage of biological cells and other samples within liquid nitrogen tanks enables valuable protection for these vital research assets. The challenge with managing samples within LN2 is the labor intensive and manual process required by biobank personnel to locate, retrieve and safely transport these samples. The possible impact of temperature excursions during sample retrieval to […]

Read more »

Using Genetics to Propel Olympic Greatness

With the exponential increase in direct to consumer genetic testing in the last decade, many have taken advantage of their genetics to discover more about about their genealogy and predispositions to health conditions. With increasingly novel genetics applications, we arrive closer to living in the era of “the quantified self”. Athletigen’s sports genetics platform offers […]

Read more »

End to End Sample Management in an outsourced environment

Traditionally CROs (Clinical Research Organizations) focus on clinical trial set-up and execution. Data captured in systems such as IRT (interactive response technology – also known as IVR/IWR), laboratory databases and EDC (Electronic Data Capture) systems deployed during clinical trial execution are usually locked after the last patient has completed the trial and data are cleaned […]

Read more »

Precision medicine in action toward a cure to Crohn’s disease

For the 1.6 million Americans suffering from Crohn’s disease and ulcerative colitis, health management is a constant battle.  It is unclear why people develop inflammatory bowel diseases (IBD), and there is no known cure.  One thing doctors and patients are certain of is that current therapies are inadequate and treatment is inconsistently administered. In order […]

Read more »

Brooks’ Acquisition of BioStorage Technologies Promises Exciting New Integrated Sample Management Solutions

The New Year provides us a moment to reflect on what our industry has accomplished in supporting advancements in medical research and is a time to focus on where the industry is going in the future.  Today, bioscience research and development companies are challenged by government regulations, cost pressures by payers, declining research productivity and […]

Read more »

Saliva Collection Kits Designed for Automated DNA Extraction and Processing

The health and wellness market is on an upswing as consumers are seeking fast, easy and cost-effective ways to better understand their genetic ethnicity, family history and health status. Companies like Ancestry.com and 23andme are examples of direct-to-consumer genetic testing companies that are using the collection of saliva to evaluate the DNA of individual. While […]

Read more »

‘Mastering Institutional Biospecimen Management’ Part Two

Part 1 in the November Biosample Buzz covered the business case including current challenges, major drivers, stakeholder engagement, requirements specification, solution selection, business plan and funding. Part 2 in the 2 part series below covers implementation & ongoing management including contract management, solution development and implementation, phased roll-out, tiered support & ongoing management (enhancement/operation) and […]

Read more »

JDRF – Turning Type One into Type None

Next generation therapies to ultimately cure and prevent type 1 diabetes Juvenile Diabetes Research Foundation (JDRF) is a leader the development of next-generation therapies like artificial pancreas technology, beta cell encapsulation, smart insulin that can turn on and off in response to blood sugar levels and, ultimately, methods for curing and preventing T1D. Driving this […]

Read more »

‘Mastering Institutional Biospecimen Management’

Some academic research organizations are hindered by their current biobanking systems infrastructure, functional capabilities and support organizations. Historic development of biobank capabilities within individual departments and even by principal investigators are sometimes costly, high risk, difficult to manage and limited in functional capabilities. The compelling drivers for an institutionally supported system are significant reduction in […]

Read more »